Sulpirid induzierte Dystonie bei einem Patienten mit Tourette-Syndrom - eine Schlaganfall ähnliche Präsentation

Zusammenfassung

Wir berichten über den Fall einer Sulpirid-induzierten Dystonie bei einem Patienten mit einem bekannten Tourette Syndrom. Aufgrund des plötzlichen Auftretens einer schlaganfallähnlichen Symptomatik während einer körperlichen Belastung war die eigentliche Dystoniediagnose erschwert. Nach Ausschluss einer vaskulären Ursache (Blutung, Gefäßdissektion, etc.) durch geeigneter Bildgebung wurde Biperiden infundiert, welche zum sofortigen Verschwinden der Dystonie führte.

Abstract

We present a case of a 23-year-old male Caucasian patient admitted to the emergency department because of an acute onset of difficulty of articulation, weakness of the left arm, throat- and neck pain. An emergency CT & MRI of the brain showed no abnormalities. The Patient had started visiting a new neurologist three weeks before admission and received Sulpiride against Tourette syndrome (TS) in a rapid escalation manner over a short period. Sulpiride induced dystonia and other neurological symptoms that were clinically masked by dystonic and clonic tics of the known TS. 5 mg Biperiden (anticholinergic agent) was slowly injected intravenously under monitor condition. The Patient reported an immediate disappearance of articulation difficulties, left arm movement, and cervical and neck pain. After discontinuing Sulpiride the patient did not develop such attacks anymore and could be discharged the next day. This case shows the development of dystonia in correlation to the use of Sulpiride, which involved the cervical region, the laryngeal muscles, and the left upper extremity. Our case is of particular interest to neurologists and psychiatrists, because of their involvement in the treatment of TS. Therefore, young neurologists must be aware of such complications when thinking of differential diagnosis in movement disorders particularly in TS.

Schlüsselwörter

Sulpirid - Dystonie - Tourette Syndrom - unerwünschte Effekte

Key words

Sulpirid - Tourette Syndrom - Dystonie

Publication History

Received: 04 October 2020

Accepted: 07 November 2021

Article published online:
12 January 2022

• Literatur

• 1 MHRA: WHO Causality assessment. Good Pharmacovigil. Pract. Guid.. 2009 39.
• 2 Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet. 2000; 356: 1255-1259
• 3 Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberst EA, Janecek E, Domecq C. DJ G. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30: 239-245
• 4 Roessner V, Plessen KJ, Rothenberger A. et al. European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment. Eur Child Adolesc Psychiatry 2011; 20: 173-196
• 5 Fountoulakis KN, Iacovides A, St Kaprinis G. Successful treatment of Tourette's disorder with amisulpride. Ann Pharmacother 2004; 38: 901
• 6 Eapen V V, Katona CLE, Barnes TRE, Robertson MM. Sulpiride-induced tardive dyskinesia in a person with Gilles de la Tourette syndrome. Journal of Psychopharmacology 1993; 7: 290-292
• 7 Pringsheim T, Doja A, Belanger S, Patten S. Canadian Alliance for Monitoring & Safety of Antipsychotics in Children Guideline. Treatment recommendations for extrapyramidal side effects associated with second-generation antipsychotic use in children and youth. Paediatrics & Child Health 2011; 16: 590-598
• 8 Martino D, Karnik V, Osland S, Barnes TRE, Pringsheim TM. Movement Disorders Associated With Antipsychotic Medication in People With Schizophrenia: An Overview of Cochrane Reviews and Meta-Analysis. Can J Psychiatry [Internet]. 2018
• 9 Drug Induced Dystonia | Dystonia Medical Research Foundation Canada [Internet]. [cited 2021 Sep 19]. Available from: https://dystoniacanada.org/about-dystonia/secondary-dystonias/drug-induced